Complications with moderate-to-severe COVID-19 during hospital admissions in patients with pneumonia

Tuğçe ŞAHİN ÖZDEMİREL; Esma Sevil AKKURT; Özlem ERTAN; Mehmet Enes GÖKLER; Berna AKINCI ÖZYÜREK

doi:https://doi.org/10.32322/jhsm.946871

Makale detayları

Complications with moderate-to-severe COVID-19 during hospital admissions in patients with pneumonia

Yazarlar:

Tuğçe ŞAHİN ÖZDEMİREL | Esma Sevil AKKURT | Özlem ERTAN | Mehmet Enes GÖKLER | Berna AKINCI ÖZYÜREK

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Sağlık teşvikleri

Dergi:

Journal of Health Sciences and Medicine 2021 Vol.4 Issue 6, pp.766-771

Belge Tipi:

Makale

Yayın Tarihi:

9/2021

Belge Dili:

İngilizce

Document ID (Org No.):

2000481787

Sıklık:

İki Aylık

eISSN:

2636-8579

DOI:

https://doi.org/10.32322/jhsm.946871

Özet:

 

Introduction: Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is an infectious disease that has caused significant mortality and morbidity worldwide. COVID-19 is known to cause complications, such as myocardial damage, acute coronary syndrome, deep vein thrombosis, pulmonary embolism, arrhythmia, heart failure, acute ischemic stroke, liver damage, cytokine storms, ischemia-reperfusion damage and side effects of drug treatments. In our study, we aimed to evaluate the complications that developed during hospitalizations in patients with moderate-to-severe COVID-19 related pneumonia who were hospitalized in our COVID-19 service. 
Material and Method: This study included patients with moderate-to-severe COVID-19 pneumonia with a positive reverse transcriptase polymerase chain reaction (RT-PCR) test who were treated in our COVID-19 service between November 2020 and January 2021. Their demographic characteristics, treatment regimens, baseline laboratory values and complications during their hospitalization were retrospectively recorded.
Results: The study group had a mean age of 62.92± 14.60 years and 40.6% (n= 55) were female. Approximately 35.3% (n= 48) of the patients developed complications due to COVID-19 during their follow-up period. Of the patients with complications, 63.8% (n: 30) were male, most common complications were elevated liver enzymes (47.9%) and pulmonary thromboembolism (20.8%). Of those patients with complications, the most common comorbidities were hypertension (40.4% [n= 19]), diabetes mellitus (25.5% [n=12]) and cardiovascular disease (23.4% [n=11]). There were no significant relationships between the presence of complications and age, sex or comorbid diseases (p>0.05 for each). 
Conclusion: There are more underlying conditions, such as hypertension, diabetes mellitus, cardiovascular disease, chronic lung disease in hospitalized patients with moderate-to-severe pneumonia compared to outpatients with COVID-19 pneumonia. Complications develop, especially in the management of COVID-19 pneumonia, which affect the treatment process and patient mobilization.

Makale detayları

Complications with moderate-to-severe COVID-19 during hospital admissions in patients with pneumonia

Yazarlar: Tuğçe ŞAHİN ÖZDEMİREL | Esma Sevil AKKURT | Özlem ERTAN | Mehmet Enes GÖKLER | Berna AKINCI ÖZYÜREK

Yayıncı: MediHealth Academy Yayıncılık

Ana Başlıklar: Sağlık teşvikleri

Dergi: Journal of Health Sciences and Medicine 2021 Vol.4 Issue 6, pp.766-771

Belge Tipi: Makale

Yayın Tarihi: 9/2021

Belge Dili: İngilizce

Document ID (Org No.): 2000481787

Sıklık: İki Aylık

eISSN: 2636-8579

DOI: https://doi.org/10.32322/jhsm.946871

Sayı

Yazarlar:

Tuğçe ŞAHİN ÖZDEMİREL | Esma Sevil AKKURT | Özlem ERTAN | Mehmet Enes GÖKLER | Berna AKINCI ÖZYÜREK

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Sağlık teşvikleri

Dergi:

Journal of Health Sciences and Medicine 2021 Vol.4 Issue 6, pp.766-771

Belge Tipi:

Makale

Yayın Tarihi:

9/2021

Belge Dili:

İngilizce

Document ID (Org No.):

2000481787

Sıklık:

İki Aylık

eISSN:

2636-8579

DOI:

https://doi.org/10.32322/jhsm.946871